Small cell lung cancer (SCLC) is an aggressive disease, with patients diagnosed with either
early-stage, limited stage, or extensive stage of SCLC tumor progression. Discovering and …

Small cell lung cancer (SCLC), accounting for around 13% of all lung cancers, often results
in rapid tumor growth, early metastasis, and acquired therapeutic resistance. The POU class …

Background BRCA1-associated protein 1 (BAP1) is an ubiquitin carboxy-terminal hydrolase,
which forms a multi-protein complex with different epigenetic factors, such as ASXL1-3 and …

Recent studies have identified a previously uncharacterized protein C11orf53 (now named
POU2AF2/OCA-T1), which functions as a robust co-activator of POU2F3, the master …

In non-pharmaceutical management of COVID-19, occupancy of intensive care units (ICU)
is often used as an indicator to inform when to intensify mitigation and thus reduce SARS-CoV…

A genome-wide screen in small cell lung cancer reveals PAX9/NuRD-mediated epigenetic
enhancer silencing and tumor progression, supporting the development of novel …

Histone modification, a major epigenetic mechanism regulating gene expression through
chromatin remodeling, introduces dynamic changes in chromatin architecture. Protein arginine …

The genetic drivers of cancer are incredibly complex; they include frequent mutations in a
small number of tumor suppressors and oncogenes, as well as a large landscape of rare …

Taurine, an endogenous sulfur-containing amino acid, is found in millimolar concentrations
in mammalian tissue, and its tissue content is altered by diet, disease and aging. The …

Plants produce a large variety of lipophilic metabolites, many of which are secreted by cells
and accumulated in apoplasts. These compounds often play a role to protect plants from …